unknown
Stage
2024
Founded
1
Investors
About
Clasp Therapeutics develops next-generation precision immuno-oncology T cell engagers targeting cancer-specific mutant protein fragments to selectively destroy tumors.
Explore Clasp Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.